Lvp Gp Iii, Llc - Net Worth and Insider Trading

Lvp Gp Iii, Llc Net Worth

The estimated net worth of Lvp Gp Iii, Llc is at least $78,235 dollars as of 2024-05-30. Lvp Gp Iii, Llc is the 10% Owner of Evoke Pharma Inc and owns about 174,048 shares of Evoke Pharma Inc (EVOK) stock worth over $78,235. Details can be seen in Lvp Gp Iii, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lvp Gp Iii, Llc has not made any transactions after 2018-08-20 and currently still holds the listed stock(s).

Transaction Summary of Lvp Gp Iii, Llc

To

Lvp Gp Iii, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lvp Gp Iii, Llc owns 2 companies in total, including Evoke Pharma Inc (EVOK) , and OncoMed Pharmaceuticals Inc (OMED) .

Click here to see the complete history of Lvp Gp Iii, Llc’s form 4 insider trades.

Insider Ownership Summary of Lvp Gp Iii, Llc

Ticker Comapny Transaction Date Type of Owner
EVOK Evoke Pharma Inc 2018-08-20 10 percent owner
OMED OncoMed Pharmaceuticals Inc 2013-07-23 10 percent owner

Lvp Gp Iii, Llc Latest Holdings Summary

Lvp Gp Iii, Llc currently owns a total of 1 stock. Lvp Gp Iii, Llc owns 174,048 shares of Evoke Pharma Inc (EVOK) as of August 20, 2018, with a value of $78,235.

Latest Holdings of Lvp Gp Iii, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EVOK Evoke Pharma Inc 2018-08-20 174,048 0.45 78,235

Holding Weightings of Lvp Gp Iii, Llc


Lvp Gp Iii, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Lvp Gp Iii, Llc has made a total of 0 transactions in Evoke Pharma Inc (EVOK) over the past 5 years. The most-recent trade in Evoke Pharma Inc is the acquisition of 41,667 shares on August 20, 2018, which cost Lvp Gp Iii, Llc around $1 Million.

Insider Trading History of Lvp Gp Iii, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lvp Gp Iii, Llc Trading Performance

GuruFocus tracks the stock performance after each of Lvp Gp Iii, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lvp Gp Iii, Llc is 1.68%. GuruFocus also compares Lvp Gp Iii, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lvp Gp Iii, Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lvp Gp Iii, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lvp Gp Iii, Llc

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 32.77
Relative Return to S&P 500(%) 30.19

Lvp Gp Iii, Llc Ownership Network

Ownership Network List of Lvp Gp Iii, Llc

No Data

Ownership Network Relation of Lvp Gp Iii, Llc


Lvp Gp Iii, Llc Owned Company Details

What does Evoke Pharma Inc do?

Who are the key executives at Evoke Pharma Inc?

Lvp Gp Iii, Llc is the 10 percent owner of Evoke Pharma Inc. Other key executives at Evoke Pharma Inc include director & President and CEO David A Gonyer , Exec VP & Chief Bus. Officer Matthew J D'onofrio , and director & 10 percent owner Kenneth J Widder .

Evoke Pharma Inc (EVOK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Evoke Pharma Inc (EVOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Evoke Pharma Inc (EVOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Evoke Pharma Inc (EVOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Evoke Pharma Inc Insider Transactions

No Available Data

Lvp Gp Iii, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Lvp Gp Iii, Llc. You might contact Lvp Gp Iii, Llc via mailing address: One Embarcadero Center Suite 4050, San Francisco Ca 94111.

Discussions on Lvp Gp Iii, Llc

No discussions yet.